AI Revolution in Pharma: Large Models Enable One-Click Generation of Any Drug Development Report

Feb 15, 2025 09:45 CST Updated 09:45

Deep Intelligent Pharma

AI-Driven Drug Discovery Platform

NDC2025 Shanghai (Yangtze River Delta) New Drug Innovators Summit will be held in Shanghai on March 6-7, 2025. This conference aims to build an exchange platform for [innovative drug project collaboration and financing cooperation], covering topics such as small molecules/antibodies and XDC/peptides/nucleic acid drugs [trends and future innovation, R&D technology, disease area research, target development, and international expansion]. The audience includes investment institutions, R&D leaders, and pharmaceutical companies’ project acquisition teams. Through this large-scale new drug conference, we hope you can find potential collaborators at the event.

This conference is honored to invite Li Xing, founder and CEO of Deep Intelligent Pharma, to deliver a keynote speech: [The Epic Transformation of One-Click Large Model Writing for Any Pharmaceutical Development Report].

Introduction to Teacher Li Xing

Li Xing, Founder and CEO of Deep Intelligent Pharma, graduated from the School of Pharmaceutical Sciences at Peking University. With over 12 years of experience in new drug development departments of large multinational pharmaceutical companies, Li has worked at Pfizer, Sanofi, and Johnson & Johnson. A former member of the Johnson & Johnson China New Drug Development leadership team, Li built a 31-person team from scratch and led Johnson & Johnson's first artificial intelligence project in the Asia-Pacific region. Li is one of the few founders of an AI company with hands-on experience in new drug research and development.